ID
int64
1
9.11k
age
float64
18
102
death
int64
0
1
sex
stringclasses
2 values
hospdead
int64
0
1
slos
int64
3
343
d.time
int64
3
2.03k
dzgroup
stringclasses
8 values
dzclass
stringclasses
4 values
num.co
int64
0
9
edu
float64
0
31
income
stringclasses
4 values
scoma
float64
0
100
charges
float64
1.17k
1.44M
totcst
float64
0
633k
totmcst
float64
-102.72
711k
avtisst
float64
1
83
race
stringclasses
5 values
sps
float64
0.2
99.2
aps
float64
0
143
surv2m
float64
0
0.97
surv6m
float64
0
0.95
hday
int64
1
148
diabetes
int64
0
1
dementia
int64
0
1
ca
stringclasses
3 values
prg2m
float64
0
1
prg6m
float64
0
1
dnr
stringclasses
3 values
dnrday
float64
-88
285
meanbp
float64
0
195
wblc
float64
0
200
hrt
float64
0
300
resp
float64
0
90
temp
float64
31.7
41.7
pafi
float64
12
890
alb
float64
0.4
29
bili
float64
0.1
63
crea
float64
0.1
21.5
sod
float64
110
181
ph
float64
6.83
7.77
glucose
float64
0
1.09k
bun
float64
1
300
urine
float64
0
9k
adlp
float64
0
7
adls
float64
0
7
sfdm2
stringclasses
5 values
adlsc
float64
0
7.07
5,901
58.267
1
male
0
9
379
ARF/MOSF w/Sepsis
ARF/MOSF
0
11
$25-$50k
0
9,897
7,161.2695
2,945.64844
14.5
white
27.699219
24
0.775879
0.702881
1
0
0
no
0.8
0.8
no dnr
9
75
8
74
24
35.59375
139
2.899902
1.899902
1
124
7.459961
null
null
null
1
1
no(M2 and SIP pres)
1
5,902
67.89294
1
male
0
13
1,157
Cirrhosis
COPD/CHF/Cirrhosis
3
8
$11-$25k
0
9,953
7,496.0234
2,386.6582
10
black
19.199219
37
0.756958
0.61499
1
1
0
no
0.99
0.9
no dnr
13
115
null
104
24
37
null
2
2.799805
1.299805
134
null
null
null
null
2
0
no(M2 and SIP pres)
0
5,903
33.65399
1
male
0
16
897
CHF
COPD/CHF/Cirrhosis
3
11
under $11k
0
12,790
9,496.6484
3,280.99805
15.666664
black
26.699219
16
0.879883
0.799927
1
0
0
no
0.7
0.6
no dnr
16
89
14.099609
100
28
35.5
210.96875
3
0.799927
1
133
7.439453
null
null
null
0
0
no(M2 and SIP pres)
0
5,904
50.62799
1
female
0
5
37
Lung Cancer
Cancer
3
9
under $11k
0
3,439
2,551.7461
913.76953
16
black
25.699219
25
0.543945
0.221985
1
0
0
metastatic
0.5
0.3
no dnr
5
69
5.699219
118
26
36.29688
null
3.299805
0.599976
0.699951
132
null
null
null
null
0
null
<2 mo. follow-up
0.4948
5,905
62.65799
1
female
1
20
20
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
under $11k
26
76,847
56,111.875
28,400.5312
47.666657
white
35.695313
59
0.342957
0.22699
18
0
0
no
0.7
0.7
no dnr
20
113
5
133
12
36.19531
120
2.199707
4.199219
1.399902
135
7.40918
null
null
null
null
1
<2 mo. follow-up
1
5,906
65.83197
1
female
0
50
434
CHF
COPD/CHF/Cirrhosis
3
13
null
0
60,071
45,310.125
17,665.6875
23.25
white
17.097656
25
0.886963
0.810913
1
0
0
no
null
null
no dnr
50
105
5.099609
94
24
37
226.65625
null
null
1.699951
138
7.479492
null
null
null
5
null
null
3.855299
5,907
31.30199
0
male
0
13
1,971
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
0
11,601
8,575
3,240.44922
22.5
white
21.398438
9
0.906982
0.873901
2
0
0
no
1
0.9
no dnr
13
77
5
82
15
36.19531
167.34375
3.099609
0.5
0.799927
137
7.379883
null
null
null
6
6
adl>=4 (>=5 if sur)
6
5,908
41.18799
0
male
0
16
1,970
ARF/MOSF w/Sepsis
ARF/MOSF
1
15
null
0
35,748
27,310.6094
8,813.75781
34.666657
white
37.59375
41
0.62793
0.524902
3
0
0
no
0.5
0.5
no dnr
16
117
21.097656
157
20
39.29688
79.23438
2.5
0.899902
0.299988
129
7.449219
null
null
null
null
0
no(M2 and SIP pres)
0
5,909
67.10199
1
male
0
4
1,776
CHF
COPD/CHF/Cirrhosis
6
10
under $11k
0
3,856
2,844.5586
1,087.89941
5
black
21.5
34
0.783936
0.653931
2
1
0
yes
null
null
no dnr
4
77
6.5
50
20
35.79688
275.1875
null
null
1.699951
144
7.419922
null
null
null
null
null
null
3.169922
5,910
75.10498
1
male
0
9
1,172
CHF
COPD/CHF/Cirrhosis
3
8
under $11k
0
5,940
4,563.8242
1,229.48926
8
black
22
33
0.802979
0.681885
1
0
0
no
0.95
0.9
no dnr
9
122
3.799805
42
26
36
331.375
3.399902
1
1.299805
139
7.449219
null
null
null
1
1
SIP>=30
1
5,911
63.98898
1
male
0
9
1,304
COPD
COPD/CHF/Cirrhosis
1
8
under $11k
0
8,977
6,760.8672
2,243.16992
21
white
24.5
34
0.816895
0.702881
1
0
0
no
0.8
0.7
no dnr
9
61
11.5
126
38
36.5
240.78125
null
0.599976
0.599976
137
7.349609
null
null
null
2
null
SIP>=30
1.839
5,912
64.36694
1
female
0
17
151
Colon Cancer
Cancer
2
11
under $11k
0
12,585
9,749.75
3,043.78906
13.333328
white
17.5
17
0.81189
0.596924
1
1
0
metastatic
0.9
0.5
no dnr
17
71
10.599609
80
24
36.39844
null
null
0.699951
0.899902
131
null
null
null
null
2
4
no(M2 and SIP pres)
4
5,913
32.85098
1
female
0
43
1,659
ARF/MOSF w/Sepsis
ARF/MOSF
2
7
null
0
100,792
74,970.9375
34,048.8438
31.5
black
26.796875
42
0.820923
0.760986
13
0
0
no
0.8
0.8
no dnr
43
160
12.5
126
20
36
300
2.199707
0.799927
2
134
7.389648
null
null
null
null
6
null
6
5,914
72.15094
1
male
0
9
169
Lung Cancer
Cancer
3
8
under $11k
0
6,397
null
null
9
black
22.5
18
0.560913
0.238983
1
0
0
metastatic
0.2
0
no dnr
9
109
19.097656
112
24
36
349
3.399902
0.399963
0.899902
136
7.459961
null
null
null
2
null
null
1.839
5,915
60.89499
1
female
1
8
8
Lung Cancer
Cancer
2
null
under $11k
0
6,031
4,530.5781
1,616.38965
17
white
32.898438
32
0.299988
0.050995
1
0
0
metastatic
0
0
dnr after sadm
3
119
26.699219
112
32
36.19531
164.84375
3.099609
0.599976
0.899902
132
7.469727
null
null
null
null
6
<2 mo. follow-up
6
5,916
77.95795
1
male
1
3
3
MOSF w/Malig
ARF/MOSF
2
13
under $11k
26
11,693
9,303.3516
4,135.51953
25
white
27.199219
37
0.28894
0.178986
11
1
0
metastatic
null
null
dnr before sadm
-10
87
9.099609
112
16
35.59375
null
null
null
3.699707
139
null
null
null
null
null
4
<2 mo. follow-up
4
5,917
69.35797
1
male
0
16
124
CHF
COPD/CHF/Cirrhosis
2
8
null
0
11,617
8,792.6953
2,636.23828
17.333328
white
21.597656
28
0.829956
0.721924
1
0
0
no
0.5
0.3
dnr after sadm
1
71
5.699219
80
24
36.5
null
3.099609
1.099854
1.799805
131
null
null
null
null
null
0
adl>=4 (>=5 if sur)
0
5,918
65.98999
1
male
1
3
3
MOSF w/Malig
ARF/MOSF
3
13
under $11k
100
8,416
6,332.2227
2,555.22852
22
black
79.1875
73
0
0
8
0
0
metastatic
0
0
dnr after sadm
1
0
10.898438
0
0
37.69531
114.28125
2.899902
2.599609
1.099854
129
7.429688
null
null
null
null
5
<2 mo. follow-up
5
5,919
55.12698
0
male
0
10
1,959
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
null
0
21,427
15,261.8984
6,027.04688
17
white
16.5
9
0.895996
0.858887
3
0
0
no
0.8
0.7
no dnr
10
109
8.099609
60
20
36.69531
310
3.299805
0.799927
0.799927
132
7.439453
null
null
null
0
0
no(M2 and SIP pres)
0
5,920
71.73395
0
female
0
15
1,954
ARF/MOSF w/Sepsis
ARF/MOSF
3
null
under $11k
0
23,022
17,563.1094
6,330.14844
20.333328
white
26.398438
45
0.712891
0.625977
3
1
1
no
0.95
0.95
no dnr
15
143
14.699219
138
40
39.19531
202.5
2.399902
0.399963
0.699951
147
7.509766
null
null
null
1
0
no(M2 and SIP pres)
0
5,921
76.97498
1
female
1
21
21
MOSF w/Malig
ARF/MOSF
2
4
under $11k
0
68,081
49,404.1562
25,860.3906
56
white
28.097656
44
0.426941
0.307983
6
0
0
metastatic
null
null
dnr after sadm
17
55
61.195313
119
14
36.29688
266.625
1.799805
0.699951
0.399963
143
7.25
null
null
null
null
0
<2 mo. follow-up
0
5,922
71.784
1
female
0
5
257
Lung Cancer
Cancer
3
8
$11-$25k
0
3,535
2,658.6289
999.87988
10
white
21.296875
17
0.593994
0.27594
1
0
0
metastatic
null
null
no dnr
5
97
10.699219
105
24
36.5
323.75
null
0.299988
0.799927
130
7.459961
null
null
null
0
null
no(M2 and SIP pres)
0.4948
5,923
59.35098
1
male
0
27
161
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
$25-$50k
0
72,570
56,103.75
20,849.3594
38
white
21.5
58
0.805908
0.741943
15
1
0
no
0.9
0.8
no dnr
27
57
null
67
28
38.5
208.15625
1.299805
1
1.599854
156
7.449219
null
null
null
null
6
SIP>=30
6
5,924
73.51099
0
female
0
27
1,952
ARF/MOSF w/Sepsis
ARF/MOSF
1
10
$11-$25k
41
100,583
74,381.9375
28,879.0469
22.5
white
31.097656
55
0.314941
0.201996
26
0
0
no
0.1
0.001
no dnr
27
47
9.5
122
36
36.09375
227.5
2.5
0.399963
1.099854
134
7.529297
null
null
null
null
0
SIP>=30
0
5,925
44.61099
1
male
1
25
25
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
under $11k
0
104,117
76,492.125
36,472.9375
31.75
black
29.699219
57
0.713989
0.625977
49
0
0
no
0.5
0.2
dnr after sadm
24
149
5.699219
156
40
39.09375
234.28125
2.299805
5.699219
0.799927
133
7.40918
null
null
null
null
0
<2 mo. follow-up
0
5,926
56.94199
1
male
1
18
18
Cirrhosis
COPD/CHF/Cirrhosis
3
8
$11-$25k
9
50,110
38,838.6562
12,690.6328
48
white
36.09375
51
0.404968
0.20697
1
0
0
no
0.5
0.25
dnr after sadm
17
112
20.699219
130
31
35.89844
128.78125
1.599854
3.599609
0.699951
131
7.399414
null
null
null
null
3
<2 mo. follow-up
3
5,927
57.46997
1
female
0
9
183
CHF
COPD/CHF/Cirrhosis
4
null
null
0
7,984
6,035.125
2,222.56836
10.5
white
27.597656
22
0.791992
0.664917
1
1
0
no
0.1
0.001
dnr after sadm
3
66
11.099609
70
24
35
191.8125
3.099609
1.899902
0.899902
130
7.459961
null
null
null
null
2
adl>=4 (>=5 if sur)
2
5,928
71.13495
1
female
1
47
47
ARF/MOSF w/Sepsis
ARF/MOSF
3
null
under $11k
44
148,311
115,883.312
48,308.7188
31
black
21.898438
55
0.563965
0.451965
87
1
0
no
0.5
0.1
dnr after sadm
45
118
21
80
32
38.39844
317.0625
2.099609
2.399902
2.399902
144
7.419922
null
null
null
null
null
<2 mo. follow-up
4.307617
5,929
68.75299
1
male
1
45
45
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
0
123,218
96,347.0625
27,905.375
49.5
white
38.195313
72
0.481995
0.363953
1
0
0
no
0.1
0.001
dnr after sadm
42
52
2.599609
122
28
36.79688
132.71875
1.599854
1.599854
1.299805
142
7.329102
null
null
null
null
null
<2 mo. follow-up
2.821777
5,930
66.08398
1
male
1
98
98
ARF/MOSF w/Sepsis
ARF/MOSF
2
14
$11-$25k
0
125,092
127,136
50,219.0312
49.5
white
32
60
0.577881
0.46698
9
1
0
no
0.9
0.7
dnr after sadm
67
148
20.398438
132
52
37.39844
93.32812
2.199707
0.299988
1.099854
139
7.439453
null
null
null
null
1
adl>=4 (>=5 if sur)
1
5,931
58.086
0
male
0
11
1,948
CHF
COPD/CHF/Cirrhosis
3
null
null
0
7,472
5,659.6719
1,477.38965
14.5
white
21
19
0.870972
0.785889
1
1
0
no
0.75
0.5
no dnr
11
76
11.898438
104
24
36
null
3.399902
0.899902
1.099854
134
null
null
null
null
null
null
null
3.340332
5,932
19.674
1
male
1
33
33
ARF/MOSF w/Sepsis
ARF/MOSF
0
14
null
100
137,877
99,592.1875
59,083.875
57.5
white
33.296875
66
0.389954
0.270996
4
0
0
no
0.1
0.001
no dnr
33
105
22
146
14
39.19531
252.5
1.899902
9.699219
7.899414
148
7.419922
null
null
null
null
null
<2 mo. follow-up
3.460449
5,933
69.09497
1
male
0
23
187
ARF/MOSF w/Sepsis
ARF/MOSF
4
12
under $11k
0
22,671
16,697.625
6,196.6875
15.666664
white
30.796875
24
0.645996
0.545898
2
1
0
no
0.75
0.5
dnr after sadm
4
79
9.798828
107
24
36
128.75
null
null
1.099854
126
7.329102
null
null
null
1
null
no(M2 and SIP pres)
1.1669
5,934
70.11096
1
male
0
92
165
ARF/MOSF w/Sepsis
ARF/MOSF
2
14
$11-$25k
0
135,625
99,232.4375
41,050.9688
35.25
white
23.898438
38
0.670898
0.574951
11
1
0
yes
0.1
0.001
no dnr
92
66
26.398438
110
24
38.89844
207.5
2
0.399963
1.099854
127
7.439453
null
null
null
null
0
SIP>=30
0
5,935
61.17499
1
male
1
21
21
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
0
60,984
46,833.125
16,003.9141
49.333313
white
31.5
64
0.69397
0.602905
1
0
0
no
0.8
1
dnr after sadm
18
54
23.597656
73
12
36.5
173.3125
1.199951
0.399963
4.099609
131
7.399414
null
null
null
null
3
<2 mo. follow-up
3
5,936
52.33899
0
female
0
7
1,944
Cirrhosis
COPD/CHF/Cirrhosis
3
10
under $11k
9
4,351
null
null
8
black
18.5
12
0.828979
0.720947
1
0
0
no
0.8
0.5
no dnr
7
99
5.199219
102
20
37
null
3.599609
1.399902
0.899902
132
null
null
null
null
null
7
no(M2 and SIP pres)
7
5,937
69.63196
1
male
0
18
385
CHF
COPD/CHF/Cirrhosis
4
null
null
0
11,426
8,963.9688
1,703.00977
9.666664
white
21.699219
42
0.785889
0.657959
1
1
0
yes
0.9
0.8
no dnr
18
149
12
74
34
36
null
3.699707
1.099854
2.399902
140
null
null
null
null
1
2
no(M2 and SIP pres)
2
5,938
59.08798
1
male
0
5
310
COPD
COPD/CHF/Cirrhosis
2
10
under $11k
0
3,004
2,276.9844
587.6499
8
white
18.097656
32
0.903931
0.837891
1
0
0
no
1
1
no dnr
5
107
6.199219
120
25
36.5
238.09375
3.799805
0.5
1
141
7.359375
null
null
null
0
1
no(M2 and SIP pres)
1
5,939
74.35999
0
male
0
102
1,940
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
9
156,300
118,342.5
50,338.375
44.25
white
27.199219
54
0.615967
0.510986
7
0
0
no
0.5
0.5
no dnr
102
63
20.699219
118
36
38.59375
152
2
2.599609
1
139
7.439453
null
null
null
null
null
null
2.69043
5,940
78.45599
1
female
0
61
1,445
CHF
COPD/CHF/Cirrhosis
3
11
under $11k
0
49,368
38,919.6562
12,959.7969
15
white
17.898438
25
0.843994
0.743896
1
1
0
no
0.9
0.8
no dnr
61
66
9.5
76
20
35.59375
null
null
null
0.899902
133
null
null
null
null
2
1
SIP>=30
1
5,941
81.02399
1
male
1
11
11
Coma
Coma
2
null
under $11k
55
13,649
9,688.2344
5,697.76953
21
hispanic
26
45
0.215973
0.152985
1
0
1
no
0.2
0.1
dnr after sadm
4
67
9.398438
102
26
38.19531
137.125
3.699707
0.699951
0.899902
128
7.399414
null
null
null
null
7
<2 mo. follow-up
7
5,942
58.18997
1
female
0
14
231
ARF/MOSF w/Sepsis
ARF/MOSF
1
11
$25-$50k
0
21,747
16,633.875
6,655.10938
27.333328
white
29.398438
55
0.690918
0.599976
1
0
0
yes
0.8
0.65
no dnr
14
121
15
158
27
38.39844
182
null
0.299988
1.899902
156
7.369141
null
null
null
null
3
adl>=4 (>=5 if sur)
3
5,943
59.96198
1
female
1
17
17
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
under $11k
44
15,954
11,898.375
3,911.96875
21.333328
white
22.796875
19
0.717896
0.631958
1
0
1
no
0.9
0.6
dnr after sadm
10
71
7.699219
55
28
36.5
190
2.599609
0.299988
0.599976
131
7.359375
null
null
null
null
null
<2 mo. follow-up
4.602539
5,944
53.47299
1
male
0
16
322
ARF/MOSF w/Sepsis
ARF/MOSF
5
9
$11-$25k
0
21,176
16,458.8906
4,610.41797
22.333328
white
25
42
0.829956
0.771973
1
1
0
no
0.9
0.8
no dnr
16
106
9.699219
118
36
36.79688
191.40625
2.699707
0.299988
1.5
134
7.399414
null
null
null
null
3
no(M2 and SIP pres)
3
5,945
42.46997
1
male
0
14
536
Cirrhosis
COPD/CHF/Cirrhosis
2
11
under $11k
0
10,818
8,129.3477
2,685.29883
5.666664
white
33
42
0.671997
0.5
1
0
0
no
0.7
0.4
no dnr
14
77
14
74
20
36.79688
null
2.299805
14.5
0.399963
123
null
null
null
null
1
null
null
1.1669
5,946
97.51099
1
female
1
6
6
Coma
Coma
2
null
under $11k
55
6,582
4,682.0391
2,288.10938
13
black
23.199219
44
0.143982
0.092987
1
0
0
no
0.05
0.000125
dnr after sadm
2
72
11.398438
60
38
35.29688
204.75
4
0.899902
1.099854
137
7.439453
null
null
null
null
4
<2 mo. follow-up
4
5,947
53.81497
1
female
0
31
82
COPD
COPD/CHF/Cirrhosis
1
11
under $11k
0
21,837
16,782.0469
3,897.50977
8.25
white
29.097656
28
0.812988
0.696899
1
0
0
no
0.5
0.25
dnr before sadm
0
66
13.298828
132
30
35.79688
274.0625
3.099609
0.299988
0.5
138
7.449219
null
null
null
7
6
no(M2 and SIP pres)
6
5,948
67.10199
1
male
0
23
969
ARF/MOSF w/Sepsis
ARF/MOSF
6
8
$11-$25k
9
23,710
18,728.4375
5,432.46875
9.666664
black
24.5
53
0.767944
0.69397
1
1
1
no
0.4
0.25
dnr after sadm
5
105
18.898438
115
20
37.39844
351.5625
1.299805
0.299988
2.699707
144
7.419922
null
null
null
null
5
null
5
5,949
55.09698
1
male
1
5
5
ARF/MOSF w/Sepsis
ARF/MOSF
2
10
under $11k
44
9,866
7,651.3242
2,551.20898
33
white
22.597656
24
0.74292
0.662964
1
0
0
no
0.05
0.000125
dnr after sadm
3
118
16.796875
129
32
38.79688
295.1875
2.799805
1.799805
1
137
7.459961
null
null
null
null
1
<2 mo. follow-up
1
5,950
54.81497
1
female
0
17
236
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
0
23,764
17,309.9844
7,843.72656
24.666656
black
30.796875
56
0.630981
0.527954
4
0
0
yes
0.6
0.6
no dnr
17
122
14.398438
69
34
38.5
121.82812
2.199707
0.399963
4.699219
131
7.279297
null
null
null
1
1
no(M2 and SIP pres)
1
5,951
44.24597
1
male
0
10
473
COPD
COPD/CHF/Cirrhosis
5
11
under $11k
0
9,844
7,045.5039
3,383.84961
11
white
30.796875
34
0.842896
0.74292
1
0
0
no
0.5
0.3
no dnr
10
74
11.199219
114
25
35
163.96875
3.399902
1.299805
0.799927
133
7.339844
null
null
null
2
6
SIP>=30
6
5,952
65.77399
1
male
0
3
24
Lung Cancer
Cancer
1
15
$25-$50k
0
2,269
1,606.2598
834.59961
24
white
24.597656
30
0.525879
0.203979
1
0
0
metastatic
0.15
0
dnr after sadm
2
75
7.199219
138
32
36
214.96875
3.399902
0.299988
0.799927
135
7.419922
null
null
null
2
null
<2 mo. follow-up
1.839
5,953
81.22095
1
male
1
23
23
COPD
COPD/CHF/Cirrhosis
2
12
under $11k
0
24,940
18,283.5781
7,874.29688
22
white
26.5
29
0.649902
0.470947
1
0
0
no
0.8
0.2
dnr after sadm
12
106
15.199219
99
30
36
183.84375
2.799805
0.599976
1.199951
137
7.299805
null
null
null
5
2
<2 mo. follow-up
2
5,954
60.68698
1
female
1
17
17
MOSF w/Malig
ARF/MOSF
1
15
$25-$50k
37
67,389
50,678.5938
23,929.0781
50
white
34.5
53
0.155975
0.075989
10
0
0
yes
0.8
0.7
dnr after sadm
16
114
0
136
32
39.59375
293.3125
2.299805
2.399902
0.5
137
7.539062
null
null
null
null
1
<2 mo. follow-up
1
5,955
58.26099
1
male
0
13
310
MOSF w/Malig
ARF/MOSF
2
12
$11-$25k
0
9,280
7,060.2305
1,997.18945
14.5
black
24.097656
35
0.639893
0.53894
1
1
0
metastatic
0.5
0.1
no dnr
13
77
13.599609
100
24
36.19531
423.75
2.5
1.599854
1.899902
133
7.40918
null
null
null
5
5
no(M2 and SIP pres)
5
5,956
81.17999
0
female
0
9
1,928
CHF
COPD/CHF/Cirrhosis
3
12
$25-$50k
0
13,445
10,031.125
2,238.88867
17
white
21.199219
31
0.776978
0.643921
2
1
0
no
0.75
0.5
no dnr
9
81
7.599609
113
16
36.5
302.375
3.199707
0.599976
1.599854
138
7.479492
null
null
null
0
0
no(M2 and SIP pres)
0
5,957
44.63498
0
female
0
9
1,928
Cirrhosis
COPD/CHF/Cirrhosis
3
12
null
0
6,719
5,142.0195
1,692.22949
6.5
white
18.097656
34
0.880981
0.80188
1
0
0
no
0.65
0.5
no dnr
9
65
6
94
20
36.5
null
1.599854
2.799805
1.199951
133
null
null
null
null
null
null
no(M2 and SIP pres)
3.381836
5,958
43.28497
1
male
0
7
431
Cirrhosis
COPD/CHF/Cirrhosis
2
16
under $11k
0
3,861
3,065.5371
530.07959
6
white
14.798828
20
0.910889
0.849976
1
0
0
no
0.8
0.7
no dnr
7
100
7
76
15
36.69531
null
1.799805
1.299805
0.699951
137
null
null
null
null
0
null
null
0.4948
5,959
54.48898
0
female
0
4
1,926
CHF
COPD/CHF/Cirrhosis
4
12
under $11k
0
4,416
3,126.1562
2,036.19922
12
white
19.398438
14
0.893921
0.821899
1
1
0
no
0.3
0.15
no dnr
4
95
7
110
20
36.09375
337
3.899902
1
1
130
7.389648
null
null
null
3
1
no(M2 and SIP pres)
1
5,960
72.29297
1
female
1
3
3
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
$25-$50k
61
4,563
3,250.4434
2,519.32812
23
white
32.5
62
0.14798
0.070999
1
0
0
metastatic
null
null
dnr after sadm
1
59
7.699219
118
24
35.69531
375.875
2
4.699219
3.899902
133
7.389648
null
null
null
null
null
<2 mo. follow-up
4.588867
5,961
61.25098
1
male
0
81
497
ARF/MOSF w/Sepsis
ARF/MOSF
4
8
null
0
58,240
44,682.1875
10,318.5078
16
white
29.398438
54
0.734985
0.652954
1
1
0
no
0.7
0.7
dnr after sadm
18
74
15.298828
111
35
36
205.65625
2.599609
2.399902
1.099854
129
7.469727
null
null
null
7
null
null
5.199497
5,962
63.02499
1
male
0
39
521
Coma
Coma
2
null
null
55
55,836
43,521.7812
21,557.7031
16.25
white
23.597656
36
0.469971
0.396973
1
0
0
no
0.5
0.25
no dnr
39
124
13
126
32
38.19531
null
null
null
1.899902
140
null
null
null
null
null
null
null
3.48877
5,963
68.05695
1
female
1
3
3
MOSF w/Malig
ARF/MOSF
3
11
null
89
22,884
17,847.6875
6,645.27734
38
hispanic
44.09375
60
0
0
20
0
0
metastatic
0
0
dnr after sadm
2
45
18
131
40
36.19531
111.65625
null
null
1.599854
135
7.129883
null
null
null
1
0
<2 mo. follow-up
0
5,964
62.25598
1
male
0
9
10
COPD
COPD/CHF/Cirrhosis
2
7
under $11k
0
7,871
5,668.7891
2,420.72852
10
white
30.699219
40
0.599976
0.41095
1
0
0
metastatic
0.8
0.65
dnr after sadm
1
99
3.299805
136
30
35.5
281.875
2.899902
1.5
1.699951
133
7.319336
null
null
null
0
1
<2 mo. follow-up
1
5,965
69.10596
1
male
0
9
217
COPD
COPD/CHF/Cirrhosis
2
8
under $11k
0
6,378
4,818.0977
1,372.69922
10
white
17.296875
18
0.873901
0.790894
1
0
0
no
0.9
0.75
no dnr
9
87
10.699219
60
26
36.5
328.5625
3.699707
0.699951
0.899902
135
7.419922
null
null
null
null
null
null
3.506348
5,966
80.08496
1
male
0
20
83
Cirrhosis
COPD/CHF/Cirrhosis
3
10
under $11k
0
13,990
10,778.9375
2,662.5293
12
white
20.296875
29
0.644897
0.465942
1
0
0
no
0.7
0.5
dnr after sadm
5
120
9.298828
50
24
36.5
null
2.599609
4.299805
1
141
null
null
null
null
null
7
adl>=4 (>=5 if sur)
7
5,967
35.09399
0
male
0
20
1,918
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
null
0
56,032
42,128.8125
23,648.4062
35
white
18.796875
31
0.910889
0.87793
4
0
0
no
1
1
no dnr
20
107
9.5
108
12
38.5
305
1.799805
1.599854
0.699951
134
7.519531
null
null
null
null
null
no(M2 and SIP pres)
2.027344
5,968
62.67798
1
female
1
3
3
Lung Cancer
Cancer
1
10
under $11k
0
2,421
1,791.9062
1,046.95996
20
white
21.699219
14
0.609985
0.292969
1
0
0
metastatic
0.6
0.5
dnr after sadm
2
108
13.199219
96
20
36.5
233.3125
3.299805
0.799927
0.799927
132
7.359375
null
null
null
null
null
<2 mo. follow-up
2.681641
5,969
66.23096
1
male
0
17
862
COPD
COPD/CHF/Cirrhosis
5
10
under $11k
0
15,916
12,191.6875
2,976.5
16.333328
white
28.796875
39
0.701904
0.539917
3
0
0
no
0.9
0.5
no dnr
17
62
8
141
28
35.59375
147.5
3
0.899902
1
136
7.319336
null
null
null
2
6
no(M2 and SIP pres)
6
5,970
60.71698
1
male
0
11
211
ARF/MOSF w/Sepsis
ARF/MOSF
2
10
under $11k
0
22,029
17,131.5312
4,880.4375
44
white
23.796875
17
0.822998
0.763916
1
0
0
no
0.8
0.7
no dnr
11
61
10.398438
118
10
37
164.4375
3
1.399902
1
137
7.399414
null
null
null
null
null
SIP>=30
3.279297
5,971
56.63199
0
female
0
73
1,918
Coma
Coma
2
9
under $11k
0
107,288
78,264.3125
34,427.625
46.25
white
19.199219
25
0.795898
0.756958
3
1
0
no
0
0
no dnr
73
124
16.898438
72
12
39.09375
185.375
3.399902
0.799927
0.699951
135
7.449219
null
null
null
null
0
adl>=4 (>=5 if sur)
0
5,972
70.16296
1
female
0
6
1,192
CHF
COPD/CHF/Cirrhosis
3
12
under $11k
0
4,602
3,407.0176
1,459.16992
12
white
18.296875
35
0.86499
0.776978
1
0
0
no
0.9
0.6
no dnr
6
58
8
72
24
36.19531
232
3.599609
0.899902
1.799805
138
7.439453
null
null
null
2
2
no(M2 and SIP pres)
2
5,973
79.98395
1
female
0
5
778
CHF
COPD/CHF/Cirrhosis
3
7
null
0
3,243
2,459.5098
720.71973
13
white
22.597656
29
0.720947
0.564941
1
0
0
yes
0.5
0.5
no dnr
5
70
6.599609
110
24
35.09375
null
3.599609
0.599976
1.399902
133
7.339844
null
null
null
0
1
no(M2 and SIP pres)
1
5,974
57.36099
1
male
0
6
83
CHF
COPD/CHF/Cirrhosis
2
8
under $11k
0
4,543
3,403.832
1,495.2998
10
hispanic
18
23
0.898926
0.829956
1
0
0
no
0.8
0.85
no dnr
6
77
10.398438
81
24
35.09375
366.625
3.599609
0.699951
1.399902
134
7.459961
null
null
null
1
null
SIP>=30
1.1669
5,975
82.63696
0
male
0
36
1,915
ARF/MOSF w/Sepsis
ARF/MOSF
0
14
null
0
36,403
28,387.4844
9,901.22656
16.5
white
25
46
0.720947
0.634888
1
0
0
no
0.8
0.7
no dnr
36
71
20
62
24
35.69531
287.5
2.299805
0.899902
7.199219
146
7.419922
null
null
null
null
1
no(M2 and SIP pres)
1
5,976
71.42499
1
male
0
3
965
CHF
COPD/CHF/Cirrhosis
3
8
under $11k
0
2,265
1,679.8623
829.62988
17
white
24.597656
38
0.728882
0.575928
1
0
0
yes
null
null
no dnr
3
88
10
98
24
36.39844
189.5
3.299805
2.899902
1.5
134
7.369141
null
null
null
null
null
no(M2 and SIP pres)
2.604004
5,977
81.03198
1
female
1
19
19
MOSF w/Malig
ARF/MOSF
2
12
under $11k
44
76,676
53,833.0625
31,415.5781
47
black
36.09375
44
0.071991
0.025997
10
0
0
yes
0.15
0.05
dnr after sadm
6
42
20.398438
102
10
36
266.625
3.699707
1.599854
2.099609
137
7.459961
null
null
null
null
2
<2 mo. follow-up
2
5,978
71.10498
1
male
0
37
179
Lung Cancer
Cancer
1
12
under $11k
0
26,591
20,801.1719
6,071.52734
11.75
white
29.796875
16
0.35498
0.076996
1
0
0
metastatic
1
0.8
no dnr
37
80
6.099609
116
20
36.79688
416.1875
2.599609
0.199982
1.099854
131
7.389648
null
null
null
0
2
null
2
5,979
42.116
0
male
0
7
1,914
Cirrhosis
COPD/CHF/Cirrhosis
2
13
$25-$50k
0
5,568
4,211.7305
1,697.55957
15
other
26.296875
30
0.794922
0.670898
1
0
0
no
0.95
0.8
no dnr
7
119
4.5
113
20
36.59375
null
2.299805
6.399414
0.599976
133
null
null
null
null
0
0
no(M2 and SIP pres)
0
5,980
35.45499
1
male
0
30
491
Cirrhosis
COPD/CHF/Cirrhosis
3
14
null
0
40,848
31,828
10,068.3125
17.5
white
21.699219
32
0.879883
0.79895
1
0
0
no
0.9
0.85
no dnr
30
73
6.299805
109
35
38.69531
300
2.199707
2.599609
0.799927
133
7.429688
null
null
null
0
1
no(M2 and SIP pres)
1
5,981
65.11694
1
female
0
11
534
CHF
COPD/CHF/Cirrhosis
5
11
under $11k
0
13,868
10,194.6094
3,507.13867
12
black
25.398438
40
0.727905
0.574951
2
1
0
yes
0.95
0.9
no dnr
11
108
5.799805
62
28
36.09375
null
3.299805
0.599976
2.799805
135
null
null
null
null
5
5
adl>=4 (>=5 if sur)
5
5,982
64.50098
1
male
1
16
16
Cirrhosis
COPD/CHF/Cirrhosis
2
10
$11-$25k
9
73,720
52,804.9375
29,231.7188
62.666657
white
58.59375
34
0
0
19
0
0
no
0.9
0.9
no dnr
16
0
14.599609
103
6
36.69531
220
2.5
null
0.599976
135
7.509766
null
null
null
null
0
<2 mo. follow-up
0
5,983
81.37396
1
male
0
10
664
COPD
COPD/CHF/Cirrhosis
2
8
under $11k
0
9,924
7,466.3359
2,605.79883
8.5
black
24.796875
25
0.616943
0.429993
1
0
0
yes
0.5
0.5
no dnr
10
119
18.199219
107
24
36
165.6875
3.399902
0.699951
0.899902
138
7.389648
null
null
null
1
1
no(M2 and SIP pres)
1
5,984
49.659
1
female
1
5
5
Lung Cancer
Cancer
1
9
under $11k
0
4,489
3,237.5391
1,600.64941
17
black
40.898438
38
0.126984
0.006
1
0
0
metastatic
0.8
0.5
dnr after sadm
5
79
41.898438
110
28
36.59375
304.75
2.799805
0.599976
0.799927
119
7.469727
null
null
null
1
1
<2 mo. follow-up
1
5,985
54.57397
1
male
1
5
5
MOSF w/Malig
ARF/MOSF
2
9
null
0
41,318
30,086
15,741.8672
38
white
41.695313
41
0.129974
0.058998
22
0
0
yes
0
0
dnr after sadm
2
83
2.399902
128
24
35.29688
91.01562
3.099609
2.199707
0.799927
130
7.479492
null
null
null
1
0
<2 mo. follow-up
0
5,986
36.392
1
male
0
17
1,185
Cirrhosis
COPD/CHF/Cirrhosis
4
14
$11-$25k
0
10,893
8,705.5938
1,705.39941
8.333328
hispanic
24.597656
36
0.844971
0.745972
1
0
0
no
1
1
no dnr
17
96
4.799805
104
32
37.59375
null
2.599609
1.799805
2.699707
133
null
null
null
null
0
2
no(M2 and SIP pres)
2
5,987
75.48297
1
male
1
12
12
ARF/MOSF w/Sepsis
ARF/MOSF
1
10
under $11k
9
263,763
192,710
73,011.625
46.5
white
34.898438
63
0.337952
0.222992
128
0
0
no
0.1
0.001
dnr after sadm
3
66
19.296875
114
12
39
160
1.799805
5.299805
3.699707
136
7.40918
null
null
null
null
0
<2 mo. follow-up
0
5,988
71.53497
0
male
0
13
1,908
ARF/MOSF w/Sepsis
ARF/MOSF
3
4
under $11k
44
23,338
18,856.4688
6,679.78906
35.5
black
19.5
35
0.728882
0.644897
1
0
0
no
0.6
0.6
no dnr
13
108
12.099609
68
26
38.09375
242.84375
2.599609
2
1.5
134
7.399414
null
null
null
null
7
adl>=4 (>=5 if sur)
7
5,989
77.95996
1
male
0
3
26
Lung Cancer
Cancer
2
10
under $11k
0
3,146
2,199.2891
1,478.48926
15
white
22.597656
19
0.540894
0.218994
1
0
0
metastatic
0.5
0.3
no dnr
3
117
5.299805
60
22
35.5
null
3
0.199982
0.699951
128
null
null
null
null
1
null
<2 mo. follow-up
1.1669
5,990
38.86398
0
female
0
16
1,907
COPD
COPD/CHF/Cirrhosis
4
11
under $11k
0
30,316
23,582
7,429.82812
26.333328
black
25.199219
30
0.91394
0.85498
1
0
0
no
0.65
0.65
no dnr
16
117
6.099609
122
12
38.89844
167.5
3.299805
0.5
1.599854
134
7.439453
null
null
null
null
0
no(M2 and SIP pres)
0
5,991
37.29999
1
female
1
6
6
MOSF w/Malig
ARF/MOSF
1
14
under $11k
26
39,395
null
null
24
black
43.195313
78
0.019997
0.004
30
0
0
metastatic
0
0
dnr before sadm
-17
63
0.599976
108
22
36.29688
null
2.299805
13.099609
2.5
128
null
null
null
null
null
4
<2 mo. follow-up
4
5,992
83.96997
1
female
0
5
199
CHF
COPD/CHF/Cirrhosis
3
8
null
0
2,727
2,107.1406
402.90991
11
white
14.099609
28
0.868896
0.781982
1
0
0
no
0.8
0.5
no dnr
5
60
6.199219
80
20
36
318.0625
3.799805
1.199951
0.799927
138
7.459961
null
null
null
0
null
null
0.4948
5,993
46.48898
0
male
0
5
1,905
Cirrhosis
COPD/CHF/Cirrhosis
5
8
under $11k
0
3,504
2,670.8945
987.17969
6
white
20.597656
34
0.81189
0.694946
1
0
0
yes
0.85
0.75
no dnr
5
67
6
62
20
36.79688
438.0625
2.199707
4.899414
0.699951
134
7.269531
null
null
null
2
null
adl>=4 (>=5 if sur)
1.839
5,994
75.23096
0
female
0
39
1,904
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
null
0
48,176
38,014.4688
9,029.46875
22.25
white
19.796875
20
0.830933
0.773926
1
0
0
no
0.7
0.6
dnr after sadm
25
180
18.597656
116
10
38.09375
262.5
4.099609
0.699951
0.899902
135
7.399414
null
null
null
null
0
adl>=4 (>=5 if sur)
0
5,995
40.76898
1
female
0
15
368
Cirrhosis
COPD/CHF/Cirrhosis
2
12
$11-$25k
0
11,920
8,964.0859
3,010.7793
11.666664
white
25.597656
19
0.81189
0.695923
1
0
0
no
0.9
0.9
no dnr
15
64
6
114
20
38.19531
null
2.699707
1.899902
0.599976
124
null
null
null
null
2
2
no(M2 and SIP pres)
2
5,996
72.55597
1
male
1
14
14
Lung Cancer
Cancer
2
12
under $11k
0
11,540
8,652.2188
3,257.58984
16.333328
white
22.898438
26
0.54895
0.22699
1
0
0
metastatic
0.6
0.25
dnr after sadm
5
115
11.898438
68
32
36.59375
null
2.599609
0.5
0.899902
135
null
null
null
null
0
0
<2 mo. follow-up
0
5,997
68.02197
1
female
1
17
17
MOSF w/Malig
ARF/MOSF
4
null
under $11k
0
53,379
41,452.4688
14,936.7344
41.666657
black
28.199219
34
0.438965
0.319946
6
0
0
metastatic
0.3
0.2
dnr after sadm
7
102
1.599854
116
12
38.89844
344.3125
1.699951
0.699951
1.099854
162
7.349609
null
null
null
null
7
<2 mo. follow-up
7
5,998
45.98798
1
female
0
14
74
MOSF w/Malig
ARF/MOSF
1
13
$25-$50k
0
26,266
20,121.9375
7,298.84766
21.333328
white
33.296875
56
0.387939
0.269958
2
0
0
metastatic
0.8
0.7
no dnr
14
114
5.399414
136
28
36
304.4375
3.099609
3.799805
7.5
134
7.379883
null
null
null
2
4
adl>=4 (>=5 if sur)
4
5,999
81.62097
1
male
0
9
60
CHF
COPD/CHF/Cirrhosis
4
11
under $11k
0
7,208
5,522.5273
2,088.86914
6
hispanic
23.699219
36
0.690918
0.524902
1
0
0
yes
0.8
0.4
no dnr
9
71
6.599609
65
20
36.5
null
3.199707
0.5
5.599609
133
null
null
null
null
1
1
null
1
6,000
63.00897
1
male
0
18
150
Colon Cancer
Cancer
1
22
$25-$50k
0
12,734
9,802.4297
2,682.47852
13.666664
white
22.699219
18
0.72998
0.457947
1
0
0
metastatic
0.5
0.25
no dnr
18
103
14.898438
102
20
38.79688
null
3
0.399963
1.099854
132
null
null
null
null
0
0
no(M2 and SIP pres)
0